This study is a matched case-control study conducted at Prof. Dr. I.G.N.G Ngoerah General Hospital, Denpasar, Bali. Patients with a diagnosis of primary hypertension based on International ...
In the Losartan Intervention for Endpoint reduction in hypertension (LIFE) Study, the angiotensin II receptor blocker (ARB) losartan improved the patients’ prognoses compared to beta-blockers, and a ...